IMOJEV vaccine 0.5 ml (France)

The article was consulted professionally by Specialist Doctor II Huynh Thi Diem Thuy – Vaccine Consultant, Pediatrics – Newborn Department, Share99 Central Park International Health Hub.

Vietnam is a circulating region of Japanese encephalitis. There are currently no specific treatment drugs for Japanese encephalitis patients. Therefore, vaccination against Japanese encephalitis helps to prevent the risk of disease as well as the risks caused by pathology.

1. About the origin of the Japanese Encephalitis vaccine

Imojev 0.5 ml vaccine originated from Sanofi Pasteur (France), approved for circulation in Vietnam by the Drug Administration – Ministry of Health on July 5, 2018. The Japanese encephalitis vaccine IMOJEV is a live, ataction vaccine. Prepared in the form of solvents and dry freezing powders.

The Japanese Encephalitis Chimeric Virus (JE-CV)) virus vaccine is based on the Yellow Fever vaccine, a genetically reconstructed 17D (YF-17D) vaccine containing the E structural gene and pre-membrane from the Japanese Encephalitis vaccine strain SA 14-14-2.

2. Vaccine packaging and manufacturing

2.1. Packing size

One dose of freezer vaccine and 1 dose of solvent in each individual vial (type I glass), each with a vial button and flap cap (aluminum / polypropylene), accompanied by 1 syringe pump and two needles (stainless steel).

The 1-vial box contains a freezer vaccine and 1 vial of solvent, 1 syringe and 2 needles.

2.2. Form of diet

The vaccine of freeze-dried powder is white to ivory white, homage, closed into cakes, which can shrink from several sides of the vial.

Solvents are transparent solution.

After re-fulance, IMOJEV® is a colorless solution to amber.

3. Intrained and contrainttrained

3.1

IMOJEV® is used to prevent Japanese encephalitis caused by the Japanese Encephalitis virus in humans 9 months and older.

3.2 Contrainttrained

  • IMOJEV® should not be given to anyone with a history of severe allergic reactions to any component of the vaccine or who has previously experienced a severe allergic reaction after this vaccination or when vaccinating with a similar composition.
  • Vaccination must be postponed in case of fever or an urgent illness.
  • Congenital or acquired immunosuppressive weakening of cellular immunity, including immunosuppressive treatment such as chemotherapy, high-dose corticosteroids that take systemic sugar for 14 days or more.
  • IMOJEV should not be given to symptomatic HIV-infected people or asymptoatic HIV-infected people but there is evidence of impaired immune function.
  • Contrainttrained imojev vaccine® in women who are breastfeeding.

Vaccine Imojev

IMOJEV 0.5 ml vaccine originated from Sanofi Pasteur (France)

4. Dosage and how to take it

4.1 Dosage

Basic immunizations:

People 9 months and older: a dose of 0.5 ml of IMOJEV® has re-eded.

Repeat:

Children (up to 18 years old)

If long-term protection is desired, after vaccination the basic dose should be repeated a dose of IMOJEV® 0.5 ml. The time to inject the dose repeats: it is best 1 year after the injection of the basic dose, which can be up to 24 months after the injection of the basic dose.

Children who have previously been given a basic dose with the inactivated Japanese Encephalitis vaccine can also take 1 dose of IMOJEV® 0.5 ml for repeated doses, according to the recommended time for the repeat dose of the inactivated Japanese Encephalitis vaccine.

Immunity is maintained at high concentrations for at least 3 years after the injection of the base dose.

The adult

Up to 5 years after injection 1 dose of IMOJEV®things without repeat injections. Immuno-biomedity figures remain for at least 60 months after 1 dose of IMOJEV®.

4.2 Uses

When the freezer vaccine is completely re-undested with solvents accompanied by subcutaneous sugar (SC) injections.

  • People 2 years and older, the recommended injection site is the delta muscle area in the biceps.
  • From 9 months to 24 months of age, the recommended injection site is the front-side of the thigh or delta muscle area.

Note:

  • Do not inject into blood vessels.
  • Do not mix IMOJEV® with any other vaccine or injectable drug.
  • Avoid exposure to antiseptic as antiseptic inactives the viral vaccine.

Instructions for vaccine re-refund and use

Applying the erile procedure, the IMOJEV® vaccine is re-entered by pumping an entire 0.4% sodium chloride solution into a vial containing a freeze-dried powder vaccine with a syringe and a needle available in a cardboard box. Gently shaking the vial containing the vaccine, After complete dissolving, use the injection pump when withdrawing 1 dose of 0.5 ml of the re-edc conditioned mixture. Insert the second needle in the cardboard box into the syringe pump for vaccination.

The vaccine must be used immediately upon re-refund.

Destruction

After use, the remaining vaccine and containers must be safely destroyed, at best inactivation by heat or scorching, depending on local regulations.

Tuberculosis vaccination at Share99

Vaccination at Share99

5. Caution when using vaccines

For patients who are treated with systemic high-dose corticosteroids for 14 days or more than 14 days, after discontinuation of treatment should wait at least a month or longer until immune function is restored before getting vaccinated.

Due to the lack of studies on the suitability of vaccines, do not mix this vaccine with other vaccines or drugs. Use a vaccine in humans previously with immunoglobulin: To avoid the neutralization of the immunoglobulin virus in the vaccine, it is usually not vaccinated within 6 weeks, it is best within 3 months after taking immunoglobulins or blood products containing immunoglobulin, such as fresh blood or plasma.

When taking IMOJEV® at the same time as other vaccines, injections must be given in two different locations and two separate injection pumps are required.

From 12 months of age anytime, IMOJEV® can be used at the same time as measles, Mums, or Rubellavaccines, either exclusively or in combination.

For children living in places at high risk of measles, 9 months of age or older, IMOJEV® may be given at the same time as the Measles vaccine, either as a separate injection or as a combination injection with the Mumus and Rubella vaccines.

In adults, IMOJEV can be used® at the same time as the yellow fever vaccine.

6. Undesirable effects

The most commonly reported body reactions after IMOJEV injections® are headache, fatigue, discomfort and muscle pain.

Local reactions are most often reported after IMOJEV injections® pain at the injection site.

The most commonly reported body reactions are discomfort, fever, headache, and myal muscle pain in children (2 to 5 years old) previously vaccinated with a 2-dose basic Japanese encephalitis vaccine; and fever, loss of appetite and irritability in toddlers (12-24 months) who had not previously been vaccinated against The Japanese Encephalitis vaccine.

Reactions at the injection site are most commonly reported after IMOJEV injections® pain/pain sensitivity at the injection site and redness of the injection site.

Unfavorable events (AE) recorded in clinical trials are usually mild and short-term. The on-the-start of general symptoms usually occurs within 3 days after vaccination.

7. Instructions for use and storage

Store the vials in the cardboard box so that the light does not hit the jars.

Shelf life 36 months from the date of manufacture. The production date is the last semi-finished mixing/blending date.

Share99 International Health Hub is offering a package vaccination program with a variety of vaccines for a variety of subjects, from infants, young children, adults, women before and during pregnancy.
Particularly in December 2019, Share99 is free of charge for newborn Hepatitis B vaccination (immediately after birth) for babies when registering for the Package for children from 0-1 year old or from 0-2 years old.

For direct advice, please click hotline number or register online HERE. In addition, you can register for remote consultation HERE

According to IMOJEV Product Prescribing Information

SEE MORE:

  • What is the new Japanese encephalitis vaccine?
  • Which way is Japanese encephalitis transmitted?
  • Is it okay to get the Measles-Mummunization-Rubella MMR II vaccine and Japanese encephalitis close together?

About: John Smith

b1ffdb54307529964874ff53a5c5de33?s=90&r=gI am the author of Share99.net. I had been working in Vinmec International General Hospital for over 10 years. I dedicate my passion on every post in this site.

RELATED POSTS:

Leave a Comment

0 SHARES
Share
Tweet
Pin